Literature DB >> 22593241

Lipid profiles and risk of breast and ovarian cancer in the Swedish AMORIS study.

Jennifer C Melvin1, Divya Seth, Lars Holmberg, Hans Garmo, Niklas Hammar, Ingmar Jungner, Göran Walldius, Mats Lambe, Annette Wigertz, Mieke Van Hemelrijck.   

Abstract

BACKGROUND: Obesity is a risk factor for breast and ovarian cancer; the mechanisms of action are not completely understood. Perturbed lipid metabolism often accompanies obesity; we therefore ascertained the associations between lipid components and breast and ovarian cancer risk in a prospective cohort study.
METHODS: A total of 234,494 women with baseline measurements of triglycerides and total cholesterol and glucose were selected from the AMORIS database.A total of 27,394 had measurements of high-density lipoprotein, low-density lipoprotein, apolipoprotein (Apo) B, and A-I. Associations between quartiles and dichotomized values of lipid components and breast and ovarian cancer risk were analyzed using Cox proportional hazard models.
RESULTS: We identified 6,105 women diagnosed with breast cancer and 808 women diagnosed with ovarian cancer. A weak trend was observed between triglycerides and breast cancer (HR, 1.01, 95% Confidence Interval, 0.94-1.09; 0.93 (0.86-1.00) 0.91 (0.84-0.99), second, third, and fourth quartiles; P = 0.01). No other associations between lipid components and risk of breast cancer or ovarian cancer showed statistical significance.
CONCLUSIONS: A weak protective association was found between levels of triglycerides and risk of breast cancer. IMPACT: An analysis including information on tumour characteristics of ovarian cancer and breast cancer may provide more insight in possible links between lipid metabolism and the risk of these cancers. ©2012 AACR.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22593241     DOI: 10.1158/1055-9965.EPI-12-0188

Source DB:  PubMed          Journal:  Cancer Epidemiol Biomarkers Prev        ISSN: 1055-9965            Impact factor:   4.254


  26 in total

1.  Serum lipids, lipoproteins, and risk of breast cancer: a nested case-control study using multiple time points.

Authors:  Lisa J Martin; Olga Melnichouk; Ella Huszti; Philip W Connelly; Carolyn V Greenberg; Salomon Minkin; Norman F Boyd
Journal:  J Natl Cancer Inst       Date:  2015-03-28       Impact factor: 13.506

2.  Circulating Lysophosphatidylcholines, Phosphatidylcholines, Ceramides, and Sphingomyelins and Ovarian Cancer Risk: A 23-Year Prospective Study.

Authors:  Oana A Zeleznik; Clary B Clish; Peter Kraft; Julian Avila-Pacheco; A Heather Eliassen; Shelley S Tworoger
Journal:  J Natl Cancer Inst       Date:  2020-06-01       Impact factor: 13.506

3.  Ovarian Cancer Risk in Relation to Blood Cholesterol and Triglycerides.

Authors:  Britton Trabert; Cassandra A Hathaway; Megan S Rice; Eric B Rimm; Patrick M Sluss; Kathryn L Terry; Oana A Zeleznik; Shelley S Tworoger
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2021-08-17       Impact factor: 4.090

4.  Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.

Authors:  Mathilde His; Laurent Zelek; Mélanie Deschasaux; Camille Pouchieu; Emmanuelle Kesse-Guyot; Serge Hercberg; Pilar Galan; Paule Latino-Martel; Jacques Blacher; Mathilde Touvier
Journal:  Eur J Epidemiol       Date:  2014-02-13       Impact factor: 8.082

5.  Is cholesterol a mediator of cold-induced cancer?

Authors:  Chandi C Mandal; Ankit Sharma; Mahaveer S Panwar; James A Radosevich
Journal:  Tumour Biol       Date:  2016-01-21

6.  A Prospective Analysis of Circulating Plasma Metabolites Associated with Ovarian Cancer Risk.

Authors:  Clary B Clish; Shelley S Tworoger; Oana A Zeleznik; A Heather Eliassen; Peter Kraft; Elizabeth M Poole; Bernard A Rosner; Sarah Jeanfavre; Amy A Deik; Kevin Bullock; Daniel S Hitchcock; Julian Avila-Pacheco
Journal:  Cancer Res       Date:  2020-01-22       Impact factor: 12.701

7.  Serum lipid profiles and cancer risk in the context of obesity: four meta-analyses.

Authors:  Jennifer C Melvin; Lars Holmberg; Sabine Rohrmann; Massimo Loda; Mieke Van Hemelrijck
Journal:  J Cancer Epidemiol       Date:  2013-01-20

Review 8.  Impact of cholesterol-pathways on breast cancer development, a metabolic landscape.

Authors:  Alina González-Ortiz; Octavio Galindo-Hernández; Gerson N Hernández-Acevedo; Gustavo Hurtado-Ureta; Victor García-González
Journal:  J Cancer       Date:  2021-05-19       Impact factor: 4.207

9.  Metabolic syndrome biomarkers and early breast cancer in Saudi women: evidence for the presence of a systemic stress response and/or a pre-existing metabolic syndrome-related neoplasia risk?

Authors:  Majed S Alokail; Nasser Al-Daghri; Amal Abdulkareem; Hossam M Draz; Sobhy M Yakout; Abdullah M Alnaami; Shaun Sabico; Amal M Alenad; George P Chrousos
Journal:  BMC Cancer       Date:  2013-02-04       Impact factor: 4.430

10.  Metabolic syndrome and risk of ovarian and fallopian tube cancer in the United States: An analysis of linked SEER-Medicare data.

Authors:  Kara A Michels; Timothy S McNeel; Britton Trabert
Journal:  Gynecol Oncol       Date:  2019-09-05       Impact factor: 5.304

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.